Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 9 of 19
- TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolutionHealth CanadaProduct quality
- NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral SolutionFDAFailed Impurities/Degradation Specifications
- Baxter Healthcare Corporation recalls Sterile Water for IrrigationFDAPresence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
- Haleon US Holdings LLC recalls parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTHFDALabeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
- Sato Pharmaceutical Co., Ltd recalls INON ACE Antacid tablets (magnesium aluminosilicateFDAFailed Disintegration Specifications: above the time expected.
- Greenstone Llc recalls methylprednisolone tabletsFDALabeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing…
- Updated: Great White North Growers Inc. recalls certain Lunaire brand dried cannabis products due to heavy metal contaminationHealth CanadaChemical contamination
- Cipla USA, Inc. recalls Diclofenac Sodium Topical GelFDAFailed PH Specifications
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesFDASubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- Graviti Pharmaceuticals Private Limited recalls Furosemide TabletsFDAPresence of Foreign Substance
- Specialty Process Labs LLC recalls ThyroidFDASubpotent Drug
- Advanced Pharmaceutical Technology, Inc. recalls TESTO-100 CIII (testosterone 100 mg)FDALack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USPFDAFailed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- Alvogen, Inc recalls Levothyroxine Sodium TabletsFDAProduct Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
- GOLD STAR DISTRIBUTION INC recalls TYLENOL a) 500 MG. and 25 moreFDACGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Fluocinolone Acetonide Solution Topical Solution USPFDAFailed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
- Cipla USA, Inc. recalls Lanreotide InjectionFDAPresence of Particulate Matter.
- Encon Safety Products Co recalls AQ 120 GFEWFDACGMP deviations.
- BiOptimizers Magnesium Breakthrough capsules; Residue on capsulesHealth CanadaProduct quality
- Medinatura New Mexico, inc. recalls ClearLife Allergy Nasal Spray and 1 moreFDAMicrobial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as…
- Alembic Pharmaceuticals Limited recalls Fesoterodine FumarateFDAFailed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
- Signature Formulations, LLC recalls ORL Kids Mouthwash and 1 moreFDACGMP Deviations
- SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USPFDAFailed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL and 2 moreFDAPresence of particulate matter - Glass like particles.
- AvKARE recalls Rosuvastatin TabletsFDAOut of specification for dissolution.
- Octreotide for injectable suspension; Good manufacturing practices concernsHealth CanadaProduct quality
- Locametz powder for solution, kit; Out of specification (unknown impurity)Health CanadaProduct quality
- Novo Nordisk Inc. recalls Wegovy (semaglutide) InjectionFDAPresence of Particulate Matter: Hair was found in a prefilled syringe
- CareFusion 213, LLC recalls BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG)FDALack of Assurance of Sterlity
- Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
- JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)Health CanadaProduct quality
- Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension and 1 moreFDAPresence of particulate matter: potential presence of metal particulates in the product.
- Golden State Medical Supply Inc. recalls Baclofen Tablets USPFDAPresence of Foreign Tablets/Capsules
- SOMERSET THERAPEUTICS LLC recalls Cisatracurium Besylate Injection USPFDASubpotent product:out of specification assay results observed during long term stability testing.
- Novocol Pharmaceutical of Canada, Inc. recalls Benco dental Graham CHEMICAL CO. and 6 moreFDADefective container: cracked/broken cartridges
- SUN PHARMA /TARO recalls Ciclopirox ShampooFDAFailed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
- Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
- ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromisedHealth CanadaProduct quality
- Viazen Immunity: The selenium content is out of specification in the affected batch.Health CanadaProduct quality
- Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.Health CanadaProduct quality
- APO-TRAVOPROST-TIMOP PQ: missing the documented justification for the results obtained.Health CanadaProduct quality
- Cipla USA, Inc. recalls Lanthanum Carbonate chewable tabletsFDAFailed stability specifications: Out of specification for hardness test
- Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USPFDADefective container - seal not adhering to bottles
- Dr. Reddy's Laboratories, Inc. recalls Varenicline TabletsFDASub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
- Cipla USA, Inc. recalls Cinacalcet Hydrochloride TabletsFDACGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
- Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate InjectionFDAFailed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
- Glenmark Pharmaceuticals Inc., USA recalls Nebivolol TabletsFDACross Contamination with Other Products
- Fagron Compounding Services recalls Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% …FDAIncorrect Product Formulation
- Winder Laboratories, LLC recalls Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL)FDACorrect Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.